2021
DOI: 10.1007/s10924-021-02107-4
|View full text |Cite
|
Sign up to set email alerts
|

Process Optimization for the Preparation of Beta-cyhalothrin Microspheres by Using the Response Surface Methodology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 39 publications
0
6
0
Order By: Relevance
“…If the appearance of the microsphere surface is damaged or incomplete, both the EE and the final insecticidal efficiency will be decreased. 32 The morphological observation of SP microspheres by SEM showed that the microspheres were spherical in shape with surface integrity, and had good dispersibility and uniformity (no severe adhesion phenomenon was observed). According to Wang's report, 33 however, as the particle size decreased, drug release of microspheres increased owing to higher SSA, as did biological activity of microspheres.…”
Section: Discussionmentioning
confidence: 91%
“…If the appearance of the microsphere surface is damaged or incomplete, both the EE and the final insecticidal efficiency will be decreased. 32 The morphological observation of SP microspheres by SEM showed that the microspheres were spherical in shape with surface integrity, and had good dispersibility and uniformity (no severe adhesion phenomenon was observed). According to Wang's report, 33 however, as the particle size decreased, drug release of microspheres increased owing to higher SSA, as did biological activity of microspheres.…”
Section: Discussionmentioning
confidence: 91%
“…This was consistent with the data listed in Table , where the significant effects on the encapsulation were found in the order of CTS concentration, mass ratio, and CAP concentration. Different from the approximately circular curves in Figure b,d, an elliptical contour was observed in Figure f, indicating that the combined effect of mass ratio and CAP concentration is significant. , From the above experimental design, the optimal conditions of the three factors for the formulation preparation should be 0.89% CTS, 1.55% CAP, and a mass ratio of CTS to CAP of 1.76:1. Under these conditions, the weight of controlled release microparticles in CCF prepared from 0.15 g of CAP and 0.26 g of CTS was about 0.40 g. The LC and EE of the resulting formulation were determined to be about 28.39 ( s = 0.39%, n = 3) and 75.71% ( s = 1.03%, n = 3), respectively.…”
Section: Resultsmentioning
confidence: 99%
“…5 μL of the solution was injected into the HPLC system and separated at 25 °C using a constant flow rate of 1.0 mL/min at a detection wavelength of 230 nm. The encapsulation efficiency (EE %) of lambda-cyhalothrin was calculated according to the following eq D L .25em ( % ) = 0.975 × A a × m b m a × A b × 100 normalX ( % ) = D L .25em % × m a × A c m c × A a × 100 E E .25em ( % ) = D L normalX normalD normalL × 100 where A a is the peak area of lambda-cyhalothrin in the disrupted microcapsule suspension, A b is the peak area of lambda-cyhalothrin in the standard solution, A c is the peak area of lambda-cyhalothrin in the extraction solution, m a is the mass of the disrupted microcapsule suspension, m b is the mass of lambda-cyhalothrin in the standard solution, and m c is the mass of the lambda-cyhalothrin microcapsule suspension for extraction. X % was the content of lambda-cyhalothrin outside of the microcapsule, and DL % was the drug-loading content of the microcapsule.…”
Section: Methodsmentioning
confidence: 99%
“…5 μL of the solution was injected into the HPLC system and separated at 25 °C using a constant flow rate of 1.0 mL/min at a detection wavelength of 230 nm. The encapsulation efficiency (EE %) 38 of lambda-cyhalothrin was calculated according to the following eq 3…”
Section: Measurements Of Encapsulation Efficiency (Ee %mentioning
confidence: 99%